IDEX Biometrics ASA
IDXAF
$0.20
$0.10100.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 52.08% | 50.05% | -11.40% | -373.53% | 120.39% |
| Total Depreciation and Amortization | -5.71% | 1.45% | -68.78% | 217.87% | -134.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.12% | -223.75% | 131.02% | 52.15% | -1,111.26% |
| Change in Net Operating Assets | -141.71% | 192.83% | -80.57% | 18.11% | 53,250.00% |
| Cash from Operations | -72.10% | 45.14% | 18.77% | -46.82% | 54.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,700.00% | -114.29% | -91.36% | 1,520.00% | -58.33% |
| Cash from Investing | 1,700.00% | -114.29% | 133.33% | 112.00% | -110.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 95.21% | -2,033.33% | 10.58% | 82.22% | 44.39% |
| Issuance of Common Stock | -19.01% | -- | -- | 130.65% | -61.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 89.06% | -20.33% | -59.00% | 225.21% | -65.39% |
| Foreign Exchange rate Adjustments | -200.00% | 575.00% | 144.44% | -181.82% | 266.67% |
| Miscellaneous Cash Flow Adjustments | -200.00% | 0.00% | -- | -- | -- |
| Net Change in Cash | 203.08% | 93.16% | -202.04% | 195.39% | 0.71% |